GOLDMAN SACHS GROUP INC - 26 Jun 2025 SCHEDULE 13G Report for TAYSHA GENE THERAPIES, INC. Common Stock, par value $0.00001 per share (TSHA)

Filing Manager: GOLDMAN SACHS GROUP INC
Reporting Manager: THE GOLDMAN SACHS GROUP, INC.
Security: TAYSHA GENE THERAPIES, INC. Common Stock, par value $0.00001 per share
Symbol: TSHA
Shares outstanding: 250M shares
Disclosed Ownership: 12.7M shares
Ownership: 5.1%
Form type: SCHEDULE 13G
Filing time: 03 Jul 2025, 12:23:57 UTC
Date of event: 26 Jun 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
THE GOLDMAN SACHS GROUP, INC.	5.1%	12.7M	0	12.7M	Name:Ameen Soetan	Attorney-in-fact
GOLDMAN SACHS & CO. LLC	5.1%	12.7M	0	12.7M	Name:Ameen Soetan	Attorney-in-fact